Literature DB >> 28686792

IgG subclass deficiencies in children: Facts and fiction.

Volker Wahn1, Horst von Bernuth1,2,3,4.   

Abstract

The chance to analyse the four IgG subclasses arose with the publication of Terry and Fahey1 . Since then, a lot of new information on the role of subclasses and their deficiency states in humans has been obtained. This review tries to analyse critically our current knowledge of subclass deficiencies in children.
© 2017 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  IgG replacement; IgG subclass deficiency; IgG subclasses; children

Mesh：

Substances：

Year:  2017        PMID： 28686792     DOI： 10.1111/pai.12757

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN： 0905-6157            Impact factor:   6.377


  4 in total

1.  A reference interval for serum IgG subclasses in Chinese children.

Authors:  Zhongjuan Liu; Chuiwen Deng; Ping Li; Jingxia Wang; Lijuan Ma; Yongzhe Li; Yingchun Xu
Journal:  PLoS One       Date:  2018-03-05       Impact factor: 3.240

Review 2.  A Critical Review on the Standardization and Quality Assessment of Nonfunctional Laboratory Tests Frequently Used to Identify Inborn Errors of Immunity.

Authors:  Sandro Félix Perazzio; Patricia Palmeira; Dewton Moraes-Vasconcelos; Andréia Rangel-Santos; João Bosco de Oliveira; Luis Eduardo Coelho Andrade; Magda Carneiro-Sampaio
Journal:  Front Immunol       Date:  2021-11-09       Impact factor: 7.561

3.  Is Rituximab-Associated Hypogammaglobulinemia Always Linked to B-Cell Depletion?

Authors:  Anthie Damianaki; Marianna Tzanoudaki; Maria Kanariou; Emmanouil Liatsis; Alexandros Panos; Alexandra Soldatou; Lydia Kossiva
Journal:  Children (Basel)       Date:  2022-02-21

4.  Activated phosphoinositide 3-kinase delta syndrome misdiagnosed as anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report.

Authors:  Xiaojing Zhang; Jingjing Wang; Kun Zhu; Yanyan Jin; Haidong Fu; Jianhua Mao
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.